UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

PloS one, 2015-08, Vol.10 (8), p.e0135427

2015

Volltextzugriff (PDF)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

ESC Heart Failure, 2020-10, Vol.7 (5), p.2494-2507

2020

Volltextzugriff (PDF)

Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance

JACC. Cardiovascular imaging, 2019-12, Vol.12 (12), p.2373-2385

2019

Volltextzugriff (PDF)

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Lipids in health and disease, 2012-10, Vol.11 (1), p.132-132, Article 132

2012

Volltextzugriff (PDF)

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Journal of diabetes and its complications, 2019-11, Vol.33 (11), p.107413-107413, Article 107413

2019

Volltextzugriff (PDF)

Increased plasma myostatin in heart failure

European journal of heart failure, 2011-07, Vol.13 (7), p.734-736

2011

Volltextzugriff (PDF)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

Cardiovascular diabetology, 2011-02, Vol.10 (1), p.20-20

2011

Volltextzugriff (PDF)

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction

International journal of cardiology, 2014-03, Vol.172 (1), p.e250-e252

2014

Volltextzugriff (PDF)

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Cardiovascular diabetology, 2010-12, Vol.9 (1), p.88-88

2010

Volltextzugriff (PDF)

The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla ( Emblica officinalis ), walnut ( Juglans regia ), olive ( Olea europaea ) and red yeast rice ( Monascus purpureus ) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia

Frontiers in pharmacology, 2023-11, Vol.14, p.1280234-1280234

2023

Volltextzugriff (PDF)

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

Journal of the American College of Cardiology, 2012-02, Vol.59 (9), p.825-835

2012

Volltextzugriff (PDF)

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Lipids in health and disease, 2017-09, Vol.16 (1), p.171-171, Article 171

2017

Volltextzugriff (PDF)

Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

International journal of cardiology, 2017-12, Vol.248, p.270-273

2017

Volltextzugriff (PDF)

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study

JACC. Cardiovascular imaging, 2015-08, Vol.8 (8), p.934-946

2015

Volltextzugriff (PDF)

Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

Peptides (New York, N.Y. : 1980), 2012-10, Vol.37 (2), p.258-262

2012

Volltextzugriff (PDF)

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients

Clinical biochemistry, 2018-11, Vol.61, p.47-49

2018

Volltextzugriff (PDF)

Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Circulation. Cardiovascular imaging, 2021-01, Vol.14 (1), p.e011680-e011680

2021

Volltextzugriff (PDF)

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

The Annals of thoracic surgery, 2016-06, Vol.101 (6), p.2176-2184

2016

Volltextzugriff (PDF)

Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failure

Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2021-12, Vol.2 (4), p.541-544

2021

Volltextzugriff (PDF)

Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines

Acta Cardiologica, 2021-07, Vol.76 (4), p.375-383

2021

Volltextzugriff (PDF)

Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

International journal of cardiology, 2015-06, Vol.189, p.185-187

2015

Volltextzugriff (PDF)

LONG-TERM EFFECT OF EARLY ENALAPRIL THERAPY ON CAUSES OF DEATH IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION: A 27-YEAR FOLLOW-UP OF SOLVD IN BELGIUM

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1346-1346

2016

Volltextzugriff (PDF)

[HDL‐C/apoA‐I]: A multivessel cardiometabolic risk marker in women with T2DM

Diabetes/metabolism research and reviews, 2018-01, Vol.34 (1), p.n/a

2018

Volltextzugriff (PDF)

Elevation of plasma oncostatin M in heart failure

Future cardiology, 2017-05, Vol.13 (3), p.219-227

2017

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(157)
Webseiten
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Increased plasma myostatin in heart failure

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study

Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients

Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting

Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failure

Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines

Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

LONG-TERM EFFECT OF EARLY ENALAPRIL THERAPY ON CAUSES OF DEATH IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION: A 27-YEAR FOLLOW-UP OF SOLVD IN BELGIUM

[HDL‐C/apoA‐I]: A multivessel cardiometabolic risk marker in women with T2DM

Elevation of plasma oncostatin M in heart failure

Suchergebnisse filtern